Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells

Human Gene Therapy

Volumn 9, Issue 1, 1998, Pages 5-11

  Namba, Hiroki ^a   Tagawa, Masatoshi ^a   Iwadate, Yasuo ^b   Kimura, Masaki ^a,b   Sueyoshi, Kanji ^a   Sakiyama, Shigeru ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ANIMAL EXPERIMENT; ARTICLE; BRAIN TUMOR; CANCER INHIBITION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; MALE; NONHUMAN; RAT; SURVIVAL; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; VIRUS GENE;

EID: 0031976061     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.1-5     Document Type: Article

References (9)

1. ARIENTI, F., SULÉ-SUSO, J. MELANI, C., MACCALLI, C., BELLI, F., ILLENI, M.T., ANICHINI, A., CASCINELLI, N., COLOMBO, M.P., and PARMIANI, G. (1994). Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes. Hum. Gene Ther. 5, 1139-1150.
2. COLUMBO, B.M., BENEDETTI, S., OTTOLENGHI, S., MORA, M., POLLO, B., POLI, G., and FINOCCHIARO, G. (1995). The "bystander effect" associated of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772
3. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumor. Science 256, 1550-1552.
4. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
5. FREEMAN, S.M., RAMESH, R., SHASTRI, M., MUNSHI, A., JENSEN, A.K., and MARROGI, A.J. (1995). The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett. 92, 167-174
6. IWADATE, Y., NAMBA, H., TAGAWA, T., TAKENAGA, K., SUEYOSHI, K., and SAKIYAMA, S. (1996). In vivo bystander effect in the intracranial model with rat glioma cells reflect the clonal difference of HSV-TK positive cells. Int. J. Oncol. 9, 521-525
7. MAHALEY, M.S., Jr., METTLIN, C., NATARAJAN, N., LAWS, E.R., Jr., and PEACE, B.B. (1989). National survey of patterns of care for brain-tumor patients. J. Neurosurg. 71, 826-836.
8. MCKNIGHT, S.L. (1980). The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 8, 5949-5964.
9. VRIONIS, F.D., WU, J.K., QI, P., CANO, W., and CHERINGTON, V. (1996). Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasma in rats. J. Neurosurg. 84, 250-257